Should I Buy NVST? NVST 2026 Analysis

Should You Buy Envista Holdings Corp (NVST) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

29.100

1 Day change

17.77%

52 Week Range

29.270

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: price has already popped (+4.4%) into near-term resistance (~24.74–25.29) directly ahead of after-hours earnings.
Risk/reward is unattractive pre-earnings: options are pricing a large move (very high IV percentile), so the stock can easily gap either way.
Better decision point is post-earnings (either a breakout above ~25.29 with follow-through, or a pullback toward ~23.85 support).
Intellectia Proprietary Trading Signals
- AI Stock Picker: no signal on given stock today.
- SwingMax: No signal on given stock recently.

Technical Analysis

Trend/momentum: MACD histogram is negative (-0.127) but contracting (bearish momentum fading, not yet bullish).
RSI(6) ~65.6: leaning warm/near overbought short-term, not a fresh “low-risk” entry after today’s jump.
Moving averages: converging (transition/chop; needs a catalyst to resolve).
Key levels: Pivot ~23.85 (important support/decision line). Immediate resistance R1 ~24.74 (being tested) and R2 ~25.29 (next breakout level). Supports: S1 ~22.96, S2 ~22.41.
Short-horizon pattern stats provided: modest upside bias next day/week, but slightly negative bias over the next month (suggesting limited upside follow-through without a strong earnings beat).

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/sentiment: extremely call-heavy open interest (OI put/call ~0.01) and call-skewed volume (vol put/call ~0.2) = bullish/speculative sentiment into the event.
Event pricing: 30D implied vol ~57.75 vs historical vol ~31.4, with IV percentile ~89.24 (options market expects a large move; elevated uncertainty).
Activity: today’s option volume is far above its 30D average ("today vs avg" ~20.29), consistent with earnings positioning rather than a normal trend day.

Technical Summary

Sell

Buy

Positive Catalysts

- Analyst tone has improved recently (multiple price target raises; Stifel reiterates Buy with $27 PT).

Neutral/Negative Catalysts

- Pre-earnings entry risk: stock is at/near resistance after a strong up day; any disappointment can gap it down.
- Estimates/revisions are mixed: last 3 months show both up/down EPS revisions and more downward than upward revenue revisions.
- Profitability remains an issue: latest quarter showed a net loss and negative EPS despite revenue growth.
- No supportive “smart money” tailwind highlighted: hedge fund and insider trading trends are neutral; no congress trading data to corroborate sentiment.

Financial Performance

Latest quarter provided: 2025/Q3.
Revenue: $669.9M, +11.46% YoY (top-line growth positive).
Profitability: Net income -$30.3M (down -469.51% YoY) and EPS -$0.18 (down -460% YoY) — growth is not translating to earnings yet.
Margins: Gross margin 55.99%, +6.02% YoY (a constructive improvement that needs to persist to justify multiple expansion).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: price targets have generally been raised (Stifel $27 from $25; UBS $25 from $22; Mizuho $24 from $19; JPMorgan $22 from $20; Piper $21 from $19).
Ratings mix: still split—at least one Buy (Stifel) and an Overweight initiation (Barclays), but multiple Neutrals remain (UBS, Piper, JPMorgan, Mizuho).
Wall St pros: improving execution/utilization and potential margin upside (Spark improvements) could support re-rating.
Wall St cons: visibility on a broader dental volume rebound is still debated; some see better opportunities elsewhere until estimate revisions turn more decisively positive.

13 Analyst Rating

Wall Street analysts forecast NVST stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVST is 22.22 USD with a low forecast of 18 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

7 Hold

1 Sell

Moderate Buy

Current: 24.710

Low

Averages

22.22

High

Current: 24.710

Low

Averages

22.22

High

JPMorgan

Neutral

maintain

$22 -> $26

AI Analysis

2026-02-06

New

Reason

JPMorgan

Price Target

$22 -> $26

AI Analysis

2026-02-06

New

maintain

Neutral

Reason

JPMorgan raised the firm's price target on Envista to $26 from $22 and keeps a Neutral rating on the shares. The company reported strong Q4 results with "reasonable" 2026 outlook, the analyst tells investors in a research note.

Stifel

Buy

maintain

$27 -> $31

2026-02-06

New

Reason

Stifel

Price Target

$27 -> $31

2026-02-06

New

maintain

Buy

Reason

Stifel raised the firm's price target on Envista to $31 from $27 and keeps a Buy rating on the shares. The company seems to be growing market plus across most key categories and new product introductions should continue in 2026, the analyst tells investors in a post-earnings note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for NVST

Unlock Now

NVST Should I Buy

NVST Should I Buy

Should You Buy Envista Holdings Corp (NVST) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch